Next-generation Sequencing Market Size, Share & Trends Report

Next-generation Sequencing Market Size, Share & Trends Analysis Report By Technology (Targeted Sequencing & Resequencing), By Application (Oncology, Consumer Genomics), By Workflow, By Product, By End-use, By Region, And Segment Forecasts, 2022 - 2030

  • Report ID: 978-1-68038-428-4
  • Number of Pages: 300
  • Format: Electronic (PDF)
  • Historical Range: 2018 - 2020
  • Industry: Healthcare

Table of Contents

Chapter 1 Research Methodology & Scope
                   1.1 Information Procurement
                       1.1.1 Purchased database
                       1.1.2 GVR’s internal database
                       1.1.3 Secondary sources
                       1.1.4 Third Party Perspective
                       1.1.5 Primary Research
                   1.2 Information or Data Analysis
                   1.3 Market Formulation & Validation
                   1.4 Region Wise Market Calculation
                       1.4.1 Region wise market: Base estimates
                       1.4.2 Global market: CAGR calculation
                       1.4.3 Region based segment share calculation
Chapter 2 Executive Summary
                   2.1 Market Outlook
Chapter 3 Market Variables, Trends & Scope
                   3.1 Market Lineage Outlook
                       3.1.1 Parent market outlook
                       3.1.2 Related/ancillary market outlook
                   3.2 Cost Structure Analysis
                   3.3 User Perspective Analysis
                       3.3.1 Consumer behavior analysis
                       3.3.2 Market influencer analysis
                   3.4 Procedure Cost Analysis
                   3.5 List of Key End Users
                   3.6 Technology Overview
                       3.6.1 Technology timeline
                   3.7 Impact of COVID-19 Pandemic
                       3.7.1 Impact on the supply chain
                       3.7.2 Association of COVID-19 with next-generation sequencing
                   3.8 Market Segmentation & Scope
                       3.8.1 Market driver analysis
                           3.8.1.1 Exponentially decreasing costs for genetic sequencing
                           3.8.1.2 Development of companion diagnostics and personalized medicine
                           3.8.1.3 Rise in competition amongst prominent market entities
                           3.8.1.4 Rising clinical opportunity for NGS technology
                           3.8.1.5 Technological advancements in cloud computing and data integration
                           3.8.1.6 Growing healthcare expenditure supporting development of effective PM diagnostic & therapeutic procedures for cancer
                           3.8.1.7 Increasing prevalence of cancer
                       3.8.2 Market restraint analysis
                           3.8.2.1 Lack of computational efficiency for data management
                           3.8.2.2 Non-value based NGS reimbursement policy and regulation status
                           3.8.2.3 Challenges associated with NGS implementation
                   3.9 Penetration & Growth Prospect Mapping for Applications, 2019
                   3.10 Penetration & Growth Prospect Mapping for Prominent Industry Players, 2019
                   3.11 NGS Platform Penetration Mapping, 2019
                       3.11.1 Next generation sequencing reimbursement environment
                       3.11.2 Gap fill approach for reimbursement of NGS tests
                       3.11.3 Role of the commercial payers
                           3.11.3.1 Payer perspectives for developing coverage policy for Next-Generation Tumor Sequencing Panels (NGTS)
                           3.11.3.2 Role of diagnostic laboratories and pathology centers
                       3.11.4 North America
                           3.11.4.1 U.S.
                           3.11.4.2 Canada
                       3.11.5 Europe
                           3.11.5.1 UK
                           3.11.5.2 Germany
                           3.11.5.3 Spain
                       3.11.6 Asia Pacific
                       3.11.7 Latin America
                       3.11.8 Middle East Africa
                       3.11.9 Next-Generation Sequencing Market: Regional Market Share, 2021
                   3.12 Next-Generation Sequencing Regulatory and Political Environment
                       3.12.1 Next-Generation Sequencing North America Regulatory and Political Landscape Analysis, 2021
                           3.12.1.1 U.S.
                           3.12.1.2 Canada
                       3.12.2 Next-Generation Sequencing Europe Regulatory and Political Landscape Analysis, 2021
                           3.12.2.1 UK
                           3.12.2.2 Germany
                           3.12.2.3 France
                           3.12.2.4 Spain
                       3.12.3 Next-Generation Sequencing Asia Pacific Regulatory and Political Landscape Analysis, 2021
                           3.12.3.1 Japan
                           3.12.3.2 China
                       3.12.4 Next-Generation Sequencing Latin America Regulatory and Political Landscape Analysis, 2021
                           3.12.4.1 Brazil
                           3.12.4.2 Mexico
                           3.12.4.3 Argentina
                       3.12.5 Next-Generation Sequencing Middle East & Africa Regulatory and Political Landscape Analysis, 2021
                           3.12.5.1 South Africa
                           3.12.5.2 Qatar
                           3.12.5.3 Kuwait
                           3.12.5.4 UAE
                           3.12.5.5 Saudi Arabia
                   3.13 Next-Generation Sequencing - SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
                   3.14 Industry Analysis - Porter’s
                       3.14.1 Major deals & strategic alliances analysis
                           3.14.1.1 Joint ventures
                           3.14.1.2 Mergers & acquisitions
                           3.14.1.3 Licensing & partnership
                       3.14.2 Technology collaborations
                   3.15 Market Entry Strategies
                   3.16 Case Studies
                       3.16.1 Impact of NGS on Treatment Selection in acute myeloid leukemia (AML)
Chapter 4 Competitive Analysis
                   4.1 Recent Developments & Impact Analysis, by Key Market Participants
                   4.2 Company Categorization
                   4.3 Public Companies
                       4.3.1 List of key distributors and channel partners
                           4.3.1.1 Service providers, manufacturers, & suppliers of products
                           4.3.1.2 Key distributors and channel partners of Illumina
                               4.3.1.2.1 Americas (North, South, & Central America)
                               4.3.1.2.2 Europe
                               4.3.1.2.3 Asia/Central Pacific
                               4.3.1.2.4 Middle East & Africa
                           4.3.1.3 Service providers of ThermoFisher
                               4.3.1.3.1 North America
                               4.3.1.3.2 EMEA
                               4.3.1.3.3 Asia Pacific
                       4.3.2 Key customers
                       4.3.3 Key company market share analysis, 2019
                           4.3.3.1 Company size
                           4.3.3.2 Geographical presence
                           4.3.3.3 Product portfolio
                       4.3.4 Competitive dashboard analysis
                       4.3.5 Market differentiators
                       4.3.6 Private companies
                           4.3.6.1 List of emerging players
                           4.3.6.2 Funding outlook
                           4.3.6.3 Regional network map
                           4.3.6.4 Company market position analysis, 2019
                           4.3.6.5 List of suppliers
Chapter 5 NGS Application Estimates & Trend Analysis
                   5.1 Next-Generation Sequencing Market: Application Movement Analysis
                   5.2 Oncology
                       5.2.1 Global oncology market, 2018 - 2030 (USD Million)
                       5.2.2 Diagnostics and screening
                           5.2.2.1 Diagnostics and screening market, 2018 - 2030 (USD Million)
                           5.2.2.2 Oncology screening
                               5.2.2.2.1 Oncology screening market, 2018 - 2030 (USD Million)
                               5.2.2.2.2 Sporadic cancer screening market, 2018 - 2030 (USD Million)
                               5.2.2.2.3 Inherited cancer screening market, 2018 - 2030 (USD Million)
                           5.2.2.3 Companion diagnostics
                               5.2.2.3.1 Companion diagnostics market, 2018 - 2030 (USD Million)
                           5.2.2.4 Other diagnostics
                               5.2.2.4.1 Other diagnostics market, 2018 - 2030 (USD Million)
                       5.2.3 Research studies
                           5.2.3.1 Research studies market, 2018 - 2030 (USD Million)
                   5.3 Clinical Investigation
                       5.3.1 Global clinical investigation market, 2018 - 2030 (USD Million)
                       5.3.2 Infectious diseases
                           5.3.2.1 Global infectious diseases market, 2018 - 2030 (USD Million)
                       5.3.3 Inherited diseases
                           5.3.3.1 Global inherited diseases market, 2018 - 2030 (USD Million)
                       5.3.4 Idiopathic diseases
                           5.3.4.1 Global idiopathic diseases market, 2018 - 2030 (USD Million)
                       5.3.5 Non-communicable/other diseases
                           5.3.5.1 Global non-communicable/other diseases market, 2018 - 2030 (USD Million)
                   5.4 Reproductive Health
                       5.4.1 Global reproductive health market, 2018 - 2030 (USD Million)
                       5.4.2 NIPT
                           5.4.2.1 Global NIPT market, 2018 - 2030 (USD Million)
                           5.4.2.2 Aneuploidy
                               5.4.2.2.1 Global aneuploidy market, 2018 - 2030 (USD Million)
                           5.4.2.3 Microdeletions
                               5.4.2.3.1 Global microdeletions market, 2018 - 2030 (USD Million)
                       5.4.3 PGT
                           5.4.3.1 Global NGS PGT market, 2018 - 2030 (USD Million)
                       5.4.4 New-born/genetic screening
                           5.4.4.1 Global newborn/genetic screening market, 2018 - 2030 (USD Million)
                       5.4.5 Single gene analysis
                           5.4.5.1 Single gene analysis market, 2018 - 2030 (USD Million)
                   5.5 HLA Typing/Immune System Monitoring
                       5.5.1 Global HLA typing/immune system monitoring market, 2018 - 2030 (USD Million)
                   5.6 Metagenomics, Epidemiology & Drug Development
                       5.6.1 Global metagenomics, epidemiology & drug development market, 2018 - 2030 (USD Million)
                   5.7 Agrigenomics & Forensics
                       5.7.1 Global agrigenomics & forensics market, 2018 - 2030 (USD Million)
                   5.8 Consumer Genomics
                       5.8.1 Global consumer genomics market, 2018 - 2030 (USD Million)
Chapter 6 NGS Technology Estimates & Trend Analysis
                   6.1 Next-Generation Sequencing Market: Technology Movement Analysis
                   6.2 Whole Genome Sequencing
                       6.2.1 Global whole genome sequencing market, 2018 - 2030 (USD Million)
                   6.3 Whole Exome Sequencing
                       6.3.1 Global whole exome sequencing market, 2018 - 2030 (USD Million)
                   6.4 Targeted Sequencing & Resequencing
                       6.4.1 Global targeted sequencing & resequencing market, 2018 - 2030 (USD Million)
                       6.4.2 DNA based targeted sequencing & resequencing
                           6.4.2.1 Global DNA based targeted sequencing & resequencing market, 2018 - 2030 (USD Million)
                       6.4.3 RNA-based targeted sequencing & resequencing
                           6.4.3.1 Global RNA based targeted sequencing & resequencing market, 2018 - 2030 (USD Million)
Chapter 7 NGS Product Estimates & Trend Analysis
                   7.1 Next-Generation Sequencing Market: Product Movement Analysis
                   7.2 Platforms
                       7.2.1 Global platforms market, 2018 - 2030 (USD Million)
                       7.2.2 Sequencing Platforms
                           7.2.2.1 Global sequencing platforms market, 2018 - 2030 (USD Million)
                       7.2.3 Data Analysis Platforms
                           7.2.3.1 Global data analysis platforms market, 2018 - 2030 (USD Million)

                   7.3 Consumables
                       7.3.1 Global consumables market, 2018 - 2030 (USD Million)
                       7.3.2 Sample Preparation
                           7.3.2.1 Global sample preparation market, 2018 - 2030 (USD Million)
                       7.3.3 Target Enrichment
                           7.3.3.1 Global target enrichment consumables market, 2018 - 2030 (USD Million)
                       7.3.4 Others
                           7.3.4.1 Global other consumables market, 2018 - 2030 (USD Million)
Chapter 8 NGS Workflow Estimates & Trend Analysis
                   8.1 Next-Generation Sequencing Market: Workflow Movement Analysis
                   8.2 Pre-Sequencing
                       8.2.1 Global pre-sequencing market, 2018 - 2030 (USD Million)
                       8.2.2 NGS library preparation kits
                           8.2.2.1 Global NGS library preparation kits market, 2018 - 2030 (USD Million)
                       8.2.3 NGS semi-automated library preparation
                           8.2.3.1 Global NGS semi-automated library preparation market, 2018 - 2030 (USD Million)
                       8.2.4 NGS automated library preparation
                           8.2.4.1 Global NGS automated library preparation market, 2018 - 2030 (USD Million)
                       8.2.5 Clonal amplification
                           8.2.5.1 Global clonal amplification market, 2018 - 2030 (USD Million)
                   8.3 Sequencing
                       8.3.1 Global sequencing market, 2018 - 2030 (USD Million)
                   8.4 Data Analysis
                       8.4.1 Global data analysis market, 2018 - 2030 (USD Million)
                       8.4.2 NGS primary data analysis
                           8.4.2.1 Global NGS primary data analysis market, 2018 - 2030 (USD Million)
                       8.4.3 NGS secondary data analysis
                           8.4.3.1 Global NGS secondary data analysis market, 2018 - 2030 (USD Million)
                       8.4.4 NGS tertiary data analysis
                           8.4.4.1 Global NGS tertiary data analysis services market, 2018 - 2030 (USD Million)
Chapter 9 NGS End-use Estimates & Trend Analysis
                   9.1 Next-Generation Sequencing Market: End-Use Movement Analysis
                   9.2 Academic Research
                       9.2.1 Global academic research market, 2018 - 2030 (USD Million)
                   9.3 Clinical Research
                       9.3.1 Global clinical research market, 2018 - 2030 (USD Million)
                   9.4 Hospitals & Clinics
                       9.4.1 Global hospitals & clinics market2018 - 2030 (USD Million)
                   9.5 Pharma & Biotech Entities
                       9.5.1 Global pharma & biotech entities market, 2018 - 2030 (USD Million)
                   9.6 Other Users
                       9.6.1 Global other users market, 2018 - 2030 (USD Million)
Chapter 10 NGS Regional Estimates & Trend Analysis, by Product & Service Type, Application, Technology, Workflow, & End-use
                   10.1 Next generation sequencing market share by region, 2019 & 2027
                   10.2 Regional Market Share and Leading Players, 2019
                   10.3 North America
                       10.3.1 North America next-generation sequencing market, 2018 - 2030 (USD Million)
                       10.3.2 U.S.
                           10.3.2.1 U.S. next-generation sequencing market, 2018 - 2030 (USD Million)
                       10.3.3 Canada
                           10.3.3.1 Canada next-generation sequencing market, 2018 - 2030 (USD Million)
                   10.4 Europe
                       10.4.1 Europe next-generation sequencing market, 2018 - 2030 (USD Million)
                       10.4.2 Germany
                           10.4.2.1 Germany next-generation sequencing market, 2018 - 2030 (USD Million)
                       10.4.3 UK
                           10.4.3.1 UK next-generation sequencing market, 2018 - 2030 (USD Million)
                       10.4.4 France
                           10.4.4.1 France next-generation sequencing market, 2018 - 2030 (USD Million)
                       10.4.5 Spain
                           10.4.5.1 Spain next-generation sequencing market, 2018 - 2030 (USD Million)
                       10.4.6 Italy
                           10.4.6.1 Italy next-generation sequencing market, 2018 - 2030 (USD Million)
                   10.5 Asia Pacific
                       10.5.1 Asia Pacific next-generation sequencing market, 2018 - 2030 (USD Million)
                       10.5.2 Japan
                           10.5.2.1 Japan next-generation sequencing market, 2018 - 2030 (USD Million)
                       10.5.3 China
                           10.5.3.1 China next-generation sequencing market, 2018 - 2030 (USD Million)
                       10.5.4 India
                           10.5.4.1 India next-generation sequencing market, 2018 - 2030 (USD Million)
                       10.5.5 Australia
                           10.5.5.1 Australia next-generation sequencing market, 2018 - 2030 (USD Million)
                       10.5.6 South Korea
                           10.5.6.1 South Korea next-generation sequencing market, 2018 - 2030 (USD Million)
                   10.6 Latin America
                       10.6.1 Latin America next-generation sequencing market, 2018 - 2030 (USD Million)
                       10.6.2 Brazil
                           10.6.2.1 Brazil next-generation sequencing market, 2018 - 2030 (USD Million)
                       10.6.3 Mexico
                           10.6.3.1 Mexico next-generation sequencing market, 2018 - 2030 (USD Million)
                   10.7 Middle East & Africa
                       10.7.1 Middle East & Africa next-generation sequencing market, 2018 - 2030 (USD Million)
                       10.7.2 South Africa
                           10.7.2.1 South Africa next-generation sequencing market, 2018 - 2030 (USD Million)
                       10.7.3 Saudi Arabia
                           10.7.3.1 Saudi Arabia next-generation sequencing market, 2018 - 2030 (USD Million)
Chapter 11 Competitive Landscape
                   11.1. Strategy Framework
                   11.2. Market Participation Categorization
                   11.3. Next-Generation Sequencing Vendor’s Landscape
                   11.4. Champions
                   11.5. Innovators
                   11.6. Emerging players
                   11.7. Market pillars
                   11.8. Company Profiles
                       11.8.1 Illumina, Inc.
                           11.8.1.1 Company overview
                           11.8.1.2 Financial performance
                           11.8.1.3 Product benchmarking
                           11.8.1.4 Strategic initiatives
                       11.8.2 F. Hoffmann-La Roche Ltd.
                           11.8.2.1 Company overview
                           11.8.2.2 Financial performance
                           11.8.2.3 Product benchmarking
                           11.8.2.4 Strategic initiatives
                       11.8.3 Agilent Technologies, Inc.
                           11.8.3.1 Company overview
                           11.8.3.2 Financial performance
                           11.8.3.3 Product benchmarking
                           11.8.3.4 Strategic initiatives
                       11.8.4 PierianDx
                           11.8.4.1 Company overview
                       11.8.5 Tute Genomics
                           11.8.5.1 Company overview
                       11.8.6 Knome, Inc.
                           11.8.6.1 Company overview
                           11.8.6.2 Financial performance
                           11.8.6.3 Product benchmarking
                           11.8.6.4 Strategic initiatives
                       11.8.7 Intrexon Bioinformatics Germany GmbH
                           11.8.7.1 Company overview
                           11.8.7.2 Financial performance
                           11.8.7.3 Product benchmarking
                           11.8.7.4 Strategic initiatives
                       11.8.8 Eurofins Scientific
                           11.8.8.1 Company overview
                           11.8.8.2 Eurofins GATC Biotech GmbH
                               11.8.8.2.1 Company overview
                           11.8.8.3 Financial performance
                               11.8.8.3.1 Financial performance: Eurofins GATC Biotech GmbH
                           11.8.8.4 Product benchmarking
                           11.8.8.5 Strategic initiatives
                       11.8.9 Oxford Nanopore Technologies
                           11.8.9.1 Company overview
                           11.8.9.2 Financial performance
                           11.8.9.3 Product benchmarking
                           11.8.9.4 Strategic initiatives
                       11.8.10 Macrogen, Inc.
                           11.8.10.1 Company overview
                           11.8.10.2 Financial performance
                           11.8.10.3 Product benchmarking
                           11.8.10.4 Strategic initiatives
                       11.8.11 DNASTAR, Inc.
                           11.8.11.1 Company overview
                           11.8.11.2 Financial Performance
                           11.8.11.3 Product benchmarking
                           11.8.11.4 Strategic initiatives
                       11.8.12 Thermo Fisher Scientific, Inc.
                           11.8.12.1 Company overview
                               11.8.12.1.1 Life Technologies Corp.
                           11.8.12.2 Financial performance
                           11.8.12.3 Product benchmarking
                           11.8.12.4 Strategic initiatives
                       11.8.13 Biomatters Ltd.
                           11.8.13.1 Company overview
                           11.8.13.2 Financial performance
                           11.8.13.3 Product benchmarking
                           11.8.13.4 Strategic initiatives
                       11.8.14 QIAGEN
                           11.8.14.1 Company overview
                       11.8.15 Ingenuity
                       11.8.16 CLC Bio
                           11.8.16.2 Financial performance
                           11.8.16.3 Product benchmarking
                           11.8.16.4 Strategic initiatives
                       11.8.17 BGI
                           11.8.17.1 Company overview
                               11.8.17.1.1 Complete Genomics Incorporated
                           11.8.17.2 Financial performance
                           11.8.17.3 Product benchmarking
                           11.8.17.4 Strategic initiatives
                       11.8.18 Perkin Elmer, Inc.
                           11.8.18.1 Company overview
                           11.8.18.2 PERKINELMER GENOMICS
                           11.8.18.3 Financial performance
                           11.8.18.4 Product benchmarking
                           11.8.18.5 Strategic initiatives
                       11.8.19 Pacific Biosciences of California, Inc.
                           11.8.19.1 Company overview
                           11.8.19.2 Financial performance
                           11.8.19.3 Product benchmarking
                           11.8.19.4 Strategic initiatives
                       11.8.20 Partek Incorporated
                           11.8.20.1 Company overview
                           11.8.20.2 Financial performance
                           11.8.20.3 Product benchmarking
                           11.8.20.4 Strategic initiatives
                       11.8.21 Bio-Rad Laboratories, Inc.
                           11.8.21.1 Company overview
                       11.8.22 GnuBio
                           11.8.22.1 Company overview
                           11.8.22.2 Financial performance
                           11.8.22.3 Product benchmarking
                           11.8.22.4 Strategic initiatives
                       11.8.23 Myriad Genetics, Inc.
                           11.8.23.1 Company overview
                           11.8.23.2 Financial performance
                           11.8.23.3 Product benchmarking
                           11.8.22.4 Strategic initiatives
                       11.8.24 Hologic, Inc. (Gen-Probe Incorporated)
                           11.8.24.1 Company overview
                           11.8.24.2 Financial performance
                           11.8.24.3 Product benchmarking
                           11.8.24.4 Strategic initiatives
                       11.8.25 Horizon Discovery Group plc
                           11.8.25.1 Company overview
                           11.8.25.2 Financial performance
                           11.8.25.3 Product benchmarking
                           11.8.25.4 Strategic initiatives
                       11.8.26 LGC Limited
                           11.8.26.1 Company overview
                       11.8.27 SeraCare
                           11.8.27.1 Company overview
                           11.8.27.2 Financial performance (LGC Limited)
                           11.8.27.3 Product benchmarking
                           11.8.27.4 Strategic initiatives
                       11.8.28 Vela Diagnostics
                           11.8.28.1 Company overview
                           11.8.28.2 Financial performance
                           11.8.28.3 Product benchmarking
                           11.8.28.4 Strategic initiatives


List of Tables

TABLE 1 List of secondary sources
TABLE 2 Country share estimation
TABLE 3 Healthcare expenditure, 2021
TABLE 4 NGS top platforms
TABLE 5 Base pairs sequenced using WGS, WES, and targeted sequencing &resequencing
TABLE 6 Clonal amplification products in the market
TABLE 7 North America next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 8 North America next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 9 North America next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
TABLE 10 North America next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
TABLE 11 North America NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 12 North America NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 13 North America next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
TABLE 14 North America next generation sequencing market estimates & forecasts, by product, 2018 - 2030 (USD Million)
TABLE 15 North America next generation sequencing market estimates & forecasts, by platforms, 2018 - 2030 (USD Million)
TABLE 16 North America next generation sequencing market estimates & forecasts, by sequencing platforms, 2018 - 2030 (USD Million)
TABLE 17 North America next generation sequencing market estimates & forecasts, by data analysis platforms, 2018 - 2030 (USD Million)
TABLE 18 North America next generation sequencing market estimates & forecasts, by consumables, 2018 - 2030 (USD Million)
TABLE 19 North America next generation sequencing market estimates & forecasts, by sample preparation, 2018 - 2030 (USD Million)
TABLE 20 North America next generation sequencing market estimates & forecasts, by target enrichment, 2018 - 2030 (USD Million)
TABLE 21 North America next generation sequencing market estimates & forecasts, by other consumables, 2018 - 2030 (USD Million)
TABLE 22 North America next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 23 North America targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 24 North America next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 25 North America NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 26 North America NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 27 North America next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 28 U.S. next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 29 U.S. next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 30 U.S. next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
TABLE 31 U.S. next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
TABLE 32 U.S. NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 33 U.S. NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 34 U.S. next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
TABLE 35 U.S. next generation sequencing market estimates & forecasts, by product, 2018 - 2030 (USD Million)
TABLE 36 U.S. next generation sequencing market estimates & forecasts, by platforms, 2018 - 2030 (USD Million)
TABLE 37 U.S. next generation sequencing market estimates & forecasts, by sequencing platforms, 2018 - 2030 (USD Million)
TABLE 38 U.S. next generation sequencing market estimates & forecasts, by data analysis platforms, 2018 - 2030 (USD Million)
TABLE 39 U.S. next generation sequencing market estimates & forecasts, by consumables, 2018 - 2030 (USD Million)
TABLE 40 U.S. next generation sequencing market estimates & forecasts, by sample preparation, 2018 - 2030 (USD Million)
TABLE 41 U.S. next generation sequencing market estimates & forecasts, by target enrichment, 2018 - 2030 (USD Million)
TABLE 42 U.S. next generation sequencing market estimates & forecasts, by other consumables, 2018 - 2030 (USD Million)
TABLE 43 U.S. next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 44 U.S. targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 45 U.S. next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 46 U.S. NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 47 U.S. NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 48 U.S. next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 49 Canada next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 50 Canada next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 51 Canada next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
TABLE 52 Canada next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
TABLE 53 Canada NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 54 Canada NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 55 Canada next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
TABLE 56 Canada next generation sequencing market estimates & forecasts, by product, 2018 - 2030 (USD Million)
TABLE 57 Canada next generation sequencing market estimates & forecasts, by platforms, 2018 - 2030 (USD Million)
TABLE 58 Canada next generation sequencing market estimates & forecasts, by sequencing platforms, 2018 - 2030 (USD Million)
TABLE 59 Canada next generation sequencing market estimates & forecasts, by data analysis platforms, 2018 - 2030 (USD Million)
TABLE 60 Canada next generation sequencing market estimates & forecasts, by consumables, 2018 - 2030 (USD Million)
TABLE 61 Canada next generation sequencing market estimates & forecasts, by sample preparation, 2018 - 2030 (USD Million)
TABLE 62 Canada next generation sequencing market estimates & forecasts, by target enrichment, 2018 - 2030 (USD Million)
TABLE 63 Canada next generation sequencing market estimates & forecasts, by other consumables, 2018 - 2030 (USD Million)
TABLE 64 Canada next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 65 Canada targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 66 Canada next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 67 Canada NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 68 Canada NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 69 Canada next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 70 Europe next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 71 Europe next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 72 Europe next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
TABLE 73 Europe next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
TABLE 74 Europe NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 75 Europe NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 76 Europe next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
TABLE 77 Europe next generation sequencing market estimates & forecasts, by product, 2018 - 2030 (USD Million)
TABLE 78 Europe next generation sequencing market estimates & forecasts, by platforms, 2018 - 2030 (USD Million)
TABLE 79 Europe next generation sequencing market estimates & forecasts, by sequencing platforms, 2018 - 2030 (USD Million)
TABLE 80 Europe next generation sequencing market estimates & forecasts, by data analysis platforms, 2018 - 2030 (USD Million)
TABLE 81 Europe next generation sequencing market estimates & forecasts, by consumables, 2018 - 2030 (USD Million)
TABLE 82 Europe next generation sequencing market estimates & forecasts, by sample preparation, 2018 - 2030 (USD Million)
TABLE 83 Europe next generation sequencing market estimates & forecasts, by target enrichment, 2018 - 2030 (USD Million)
TABLE 84 Europe next generation sequencing market estimates & forecasts, by other consumables, 2018 - 2030 (USD Million)
TABLE 85 Europe next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 86 Europe targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 87 Europe next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 88 Europe NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 89 Europe NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 90 Europe next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 91 Germany next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 92 Germany next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 93 Germany next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
TABLE 94 Germany next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
TABLE 95 Germany NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 96 Germany NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 97 Germany next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
TABLE 98 Germany next generation sequencing market estimates & forecasts, by product, 2018 - 2030 (USD Million)
TABLE 99 Germany next generation sequencing market estimates & forecasts, by platforms, 2018 - 2030 (USD Million)
TABLE 100 Germany next generation sequencing market estimates & forecasts, by sequencing platforms, 2018 - 2030 (USD Million)
TABLE 101 Germany next generation sequencing market estimates & forecasts, by data analysis platforms, 2018 - 2030 (USD Million)
TABLE 102 Germany next generation sequencing market estimates & forecasts, by consumables, 2018 - 2030 (USD Million)
TABLE 103 Germany next generation sequencing market estimates & forecasts, by sample preparation, 2018 - 2030 (USD Million)
TABLE 104 Germany next generation sequencing market estimates & forecasts, by target enrichment, 2018 - 2030 (USD Million)
TABLE 105 Germany next generation sequencing market estimates & forecasts, by other consumables, 2018 - 2030 (USD Million)
TABLE 106 Germany next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 107 Germany targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 108 Germany next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 109 Germany NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 110 Germany NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 111 Germany next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 112 U.K. next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 113 U.K. next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 114 U.K. next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
TABLE 115 U.K. next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
TABLE 116 U.K. NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 117 U.K. NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 118 U.K. next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
TABLE 119 UK next generation sequencing market estimates & forecasts, by product, 2018 - 2030 (USD Million)
TABLE 120 UK next generation sequencing market estimates & forecasts, by platforms, 2018 - 2030 (USD Million)
TABLE 121 UK next generation sequencing market estimates & forecasts, by sequencing platforms, 2018 - 2030 (USD Million)
TABLE 122 UK next generation sequencing market estimates & forecasts, by data analysis platforms, 2018 - 2030 (USD Million)
TABLE 123 UK next generation sequencing market estimates & forecasts, by consumables, 2018 - 2030 (USD Million)
TABLE 124 UK next generation sequencing market estimates & forecasts, by sample preparation, 2018 - 2030 (USD Million)
TABLE 125 UK next generation sequencing market estimates & forecasts, by target enrichment, 2018 - 2030 (USD Million)
TABLE 126 UK next generation sequencing market estimates & forecasts, by other consumables, 2018 - 2030 (USD Million)
TABLE 127 U.K. next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 128 U.K. targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 129 U.K. next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 130 U.K. NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 131 U.K. NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 132 U.K. next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 133 Spain next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 134 Spain next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 135 Spain next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
TABLE 136 Spain next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
TABLE 137 Spain NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 138 Spain NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 139 Spain next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
TABLE 140 Spain next generation sequencing market estimates & forecasts, by product, 2018 - 2030 (USD Million)
TABLE 141 Spain next generation sequencing market estimates & forecasts, by platforms, 2018 - 2030 (USD Million)
TABLE 142 Spain next generation sequencing market estimates & forecasts, by sequencing platforms, 2018 - 2030 (USD Million)
TABLE 143 Spain next generation sequencing market estimates & forecasts, by data analysis platforms, 2018 - 2030 (USD Million)
TABLE 144 Spain next generation sequencing market estimates & forecasts, by consumables, 2018 - 2030 (USD Million)
TABLE 145 Spain next generation sequencing market estimates & forecasts, by sample preparation, 2018 - 2030 (USD Million)
TABLE 146 Spain next generation sequencing market estimates & forecasts, by target enrichment, 2018 - 2030 (USD Million)
TABLE 147 Spain next generation sequencing market estimates & forecasts, by other consumables, 2018 - 2030 (USD Million)
TABLE 148 Spain next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 149 Spain targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 150 Spain next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 151 Spain NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 152 Spain NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 153 Spain next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 154 France next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 155 France next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 156 France next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
TABLE 157 France next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
TABLE 158 France NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 159 France NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 160 France next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
TABLE 161 France next generation sequencing market estimates & forecasts, by product, 2018 - 2030 (USD Million)
TABLE 162 France next generation sequencing market estimates & forecasts, by platforms, 2018 - 2030 (USD Million)
TABLE 163 France next generation sequencing market estimates & forecasts, by sequencing platforms, 2018 - 2030 (USD Million)
TABLE 164 France next generation sequencing market estimates & forecasts, by data analysis platforms, 2018 - 2030 (USD Million)
TABLE 165 France next generation sequencing market estimates & forecasts, by consumables, 2018 - 2030 (USD Million)
TABLE 166 France next generation sequencing market estimates & forecasts, by sample preparation, 2018 - 2030 (USD Million)
TABLE 167 France next generation sequencing market estimates & forecasts, by target enrichment, 2018 - 2030 (USD Million)
TABLE 168 France next generation sequencing market estimates & forecasts, by other consumables, 2018 - 2030 (USD Million)
TABLE 169 France next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 170 France targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 171 France next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 172 France NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 173 France NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 174 France next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 175 Italy next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 176 Italy next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 177 Italy next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
TABLE 178 Italy next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
TABLE 179 Italy NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 180 Italy NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 181 Italy next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
TABLE 182 Italy next generation sequencing market estimates & forecasts, by product, 2018 - 2030 (USD Million)
TABLE 183 Italy next generation sequencing market estimates & forecasts, by platforms, 2018 - 2030 (USD Million)
TABLE 184 Italy next generation sequencing market estimates & forecasts, by sequencing platforms, 2018 - 2030 (USD Million)
TABLE 185 Italy next generation sequencing market estimates & forecasts, by data analysis platforms, 2018 - 2030 (USD Million)
TABLE 186 Italy next generation sequencing market estimates & forecasts, by consumables, 2018 - 2030 (USD Million)
TABLE 187 Italy next generation sequencing market estimates & forecasts, by sample preparation, 2018 - 2030 (USD Million)
TABLE 188 Italy next generation sequencing market estimates & forecasts, by target enrichment, 2018 - 2030 (USD Million)
TABLE 189 Italy next generation sequencing market estimates & forecasts, by other consumables, 2018 - 2030 (USD Million)
TABLE 190 Italy next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 191 Italy targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 192 Italy next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 193 Italy NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 194 Italy NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 195 Italy next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 196 Asia Pacific next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 197 Asia Pacific next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 198 Asia Pacific next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
TABLE 199 Asia Pacific next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
TABLE 200 Asia Pacific NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 201 Asia Pacific NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 202 Asia Pacific next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
TABLE 203 Asia Pacific next generation sequencing market estimates & forecasts, by product, 2018 - 2030 (USD Million)
TABLE 204 Asia Pacific next generation sequencing market estimates & forecasts, by platforms, 2018 - 2030 (USD Million)
TABLE 205 Asia Pacific next generation sequencing market estimates & forecasts, by sequencing platforms, 2018 - 2030 (USD Million)
TABLE 206 Asia Pacific next generation sequencing market estimates & forecasts, by data analysis platforms, 2018 - 2030 (USD Million)
TABLE 207 Asia Pacific next generation sequencing market estimates & forecasts, by consumables, 2018 - 2030 (USD Million)
TABLE 208 Asia Pacific next generation sequencing market estimates & forecasts, by sample preparation, 2018 - 2030 (USD Million)
TABLE 209 Asia Pacific next generation sequencing market estimates & forecasts, by target enrichment, 2018 - 2030 (USD Million)
TABLE 210 Asia Pacific next generation sequencing market estimates & forecasts, by other consumables, 2018 - 2030 (USD Million)
TABLE 211 Asia Pacific next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 212 Asia Pacific targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 213 Asia Pacific next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 214 Asia Pacific NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 215 Asia Pacific NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 216 Asia Pacific next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 217 Japan next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 218 Japan next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 219 Japan next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
TABLE 220 Japan next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
TABLE 221 Japan NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 222 Japan NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 223 Japan next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
TABLE 224 Japan next generation sequencing market estimates & forecasts, by product, 2018 - 2030 (USD Million)
TABLE 225 Japan next generation sequencing market estimates & forecasts, by platforms, 2018 - 2030 (USD Million)
TABLE 226 Japan next generation sequencing market estimates & forecasts, by sequencing platforms, 2018 - 2030 (USD Million)
TABLE 227 Japan next generation sequencing market estimates & forecasts, by data analysis platforms, 2018 - 2030 (USD Million)
TABLE 228 Japan next generation sequencing market estimates & forecasts, by consumables, 2018 - 2030 (USD Million)
TABLE 229 Japan next generation sequencing market estimates & forecasts, by sample preparation, 2018 - 2030 (USD Million)
TABLE 230 Japan next generation sequencing market estimates & forecasts, by target enrichment, 2018 - 2030 (USD Million)
TABLE 231 Japan next generation sequencing market estimates & forecasts, by other consumables, 2018 - 2030 (USD Million)
TABLE 232 Japan next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 233 Japan targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 234 Japan next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 235 Japan NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 236 Japan NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 237 Japan next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 238 China next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 239 China next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 240 China next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
TABLE 241 China next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
TABLE 242 China NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 243 China NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 244 China next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
TABLE 245 China next generation sequencing market estimates & forecasts, by product, 2018 - 2030 (USD Million)
TABLE 246 China next generation sequencing market estimates & forecasts, by platforms, 2018 - 2030 (USD Million)
TABLE 247 China next generation sequencing market estimates & forecasts, by sequencing platforms, 2018 - 2030 (USD Million)
TABLE 248 China next generation sequencing market estimates & forecasts, by data analysis platforms, 2018 - 2030 (USD Million)
TABLE 249 China next generation sequencing market estimates & forecasts, by consumables, 2018 - 2030 (USD Million)
TABLE 250 China next generation sequencing market estimates & forecasts, by sample preparation, 2018 - 2030 (USD Million)
TABLE 251 China next generation sequencing market estimates & forecasts, by target enrichment, 2018 - 2030 (USD Million)
TABLE 252 China next generation sequencing market estimates & forecasts, by other consumables, 2018 - 2030 (USD Million)
TABLE 253 China next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 254 China targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 255 China next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 256 China NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 257 China NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 258 China next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 259 India next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 260 India next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 261 India next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
TABLE 262 India next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
TABLE 263 India NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 264 India NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 265 India next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
TABLE 266 China next generation sequencing market estimates & forecasts, by product, 2018 - 2030 (USD Million)
TABLE 267 China next generation sequencing market estimates & forecasts, by platforms, 2018 - 2030 (USD Million)
TABLE 268 China next generation sequencing market estimates & forecasts, by sequencing platforms, 2018 - 2030 (USD Million)
TABLE 269 China next generation sequencing market estimates & forecasts, by data analysis platforms, 2018 - 2030 (USD Million)
TABLE 270 China next generation sequencing market estimates & forecasts, by consumables, 2018 - 2030 (USD Million)
TABLE 271 China next generation sequencing market estimates & forecasts, by sample preparation, 2018 - 2030 (USD Million)
TABLE 272 China next generation sequencing market estimates & forecasts, by target enrichment, 2018 - 2030 (USD Million)
TABLE 273 China next generation sequencing market estimates & forecasts, by other consumables, 2018 - 2030 (USD Million)
TABLE 274 India next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 275 India targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 276 India next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 277 India NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 278 India NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 279 India next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 280 South Korea next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 281 South Korea next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 282 South Korea next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
TABLE 283 South Korea next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
TABLE 284 South Korea NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 285 South Korea NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 286 South Korea next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
TABLE 287 South Korea next generation sequencing market estimates & forecasts, by product, 2018 - 2030 (USD Million)
TABLE 288 South Korea next generation sequencing market estimates & forecasts, by platforms, 2018 - 2030 (USD Million)
TABLE 289 South Korea next generation sequencing market estimates & forecasts, by sequencing platforms, 2018 - 2030 (USD Million)
TABLE 290 South Korea next generation sequencing market estimates & forecasts, by data analysis platforms, 2018 - 2030 (USD Million)
TABLE 291 South Korea next generation sequencing market estimates & forecasts, by consumables, 2018 - 2030 (USD Million)
TABLE 292 South Korea next generation sequencing market estimates & forecasts, by sample preparation, 2018 - 2030 (USD Million)
TABLE 293 South Korea next generation sequencing market estimates & forecasts, by target enrichment, 2018 - 2030 (USD Million)
TABLE 294 South Korea next generation sequencing market estimates & forecasts, by other consumables, 2018 - 2030 (USD Million)
TABLE 295 South Korea next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 296 South Korea targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 297 South Korea next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 298 South Korea NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 299 South Korea NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 300 South Korea next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 301 Australia next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 302 Australia next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 303 Australia next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
TABLE 304 Australia next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
TABLE 305 Australia NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 306 Australia NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 307 Australia next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
TABLE 308 Australia next generation sequencing market estimates & forecasts, by product, 2018 - 2030 (USD Million)
TABLE 309 Australia next generation sequencing market estimates & forecasts, by platforms, 2018 - 2030 (USD Million)
TABLE 310 Australia next generation sequencing market estimates & forecasts, by sequencing platforms, 2018 - 2030 (USD Million)
TABLE 311 Australia next generation sequencing market estimates & forecasts, by data analysis platforms, 2018 - 2030 (USD Million)
TABLE 312 Australia next generation sequencing market estimates & forecasts, by consumables, 2018 - 2030 (USD Million)
TABLE 313 Australia next generation sequencing market estimates & forecasts, by sample preparation, 2018 - 2030 (USD Million)
TABLE 314 Australia next generation sequencing market estimates & forecasts, by target enrichment, 2018 - 2030 (USD Million)
TABLE 315 Australia next generation sequencing market estimates & forecasts, by other consumables, 2018 - 2030 (USD Million)
TABLE 316 Australia next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 317 Australia targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 318 Australia next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 319 Australia NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 320 Australia NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 321 Australia next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 322 Latin America next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 323 Latin America next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 324 Latin America next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
TABLE 325 Latin America next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
TABLE 326 Latin America NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 327 Latin America NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 328 Latin America next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
TABLE 329 Latin America next generation sequencing market estimates & forecasts, by product, 2018 - 2030 (USD Million)
TABLE 330 Latin America next generation sequencing market estimates & forecasts, by platforms, 2018 - 2030 (USD Million)
TABLE 331 Latin America next generation sequencing market estimates & forecasts, by sequencing platforms, 2018 - 2030 (USD Million)
TABLE 332 Latin America next generation sequencing market estimates & forecasts, by data analysis platforms, 2018 - 2030 (USD Million)
TABLE 333 Latin America next generation sequencing market estimates & forecasts, by consumables, 2018 - 2030 (USD Million)
TABLE 334 Latin America next generation sequencing market estimates & forecasts, by sample preparation, 2018 - 2030 (USD Million)
TABLE 335 Latin America next generation sequencing market estimates & forecasts, by target enrichment, 2018 - 2030 (USD Million)
TABLE 336 Latin America next generation sequencing market estimates & forecasts, by other consumables, 2018 - 2030 (USD Million)
TABLE 337 Latin America next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 338 Latin America targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 339 Latin America next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 340 Latin America NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 341 Latin America NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 342 Latin America next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 343 Brazil next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 344 Brazil next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 345 Brazil next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
TABLE 346 Brazil next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
TABLE 347 Brazil NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 348 Brazil NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 349 Brazil next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
TABLE 350 Brazil next generation sequencing market estimates & forecasts, by product, 2018 - 2030 (USD Million)
TABLE 351 Brazil next generation sequencing market estimates & forecasts, by platforms, 2018 - 2030 (USD Million)
TABLE 352 Brazil next generation sequencing market estimates & forecasts, by sequencing platforms, 2018 - 2030 (USD Million)
TABLE 353 Brazil next generation sequencing market estimates & forecasts, by data analysis platforms, 2018 - 2030 (USD Million)
TABLE 354 Brazil next generation sequencing market estimates & forecasts, by consumables, 2018 - 2030 (USD Million)
TABLE 355 Brazil next generation sequencing market estimates & forecasts, by sample preparation, 2018 - 2030 (USD Million)
TABLE 356 Brazil next generation sequencing market estimates & forecasts, by target enrichment, 2018 - 2030 (USD Million)
TABLE 357 Brazil next generation sequencing market estimates & forecasts, by other consumables, 2018 - 2030 (USD Million)
TABLE 358 Brazil next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 359 Brazil targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 360 Brazil next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 361 Brazil NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 362 Brazil NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 363 Brazil next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 364 Mexico next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 365 Mexico next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 366 Mexico next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
TABLE 367 Mexico next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
TABLE 368 Mexico NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 369 Mexico NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 370 Mexico next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
TABLE 371 Mexico next generation sequencing market estimates & forecasts, by product, 2018 - 2030 (USD Million)
TABLE 372 Mexico next generation sequencing market estimates & forecasts, by platforms, 2018 - 2030 (USD Million)
TABLE 373 Mexico next generation sequencing market estimates & forecasts, by sequencing platforms, 2018 - 2030 (USD Million)
TABLE 374 Mexico next generation sequencing market estimates & forecasts, by data analysis platforms, 2018 - 2030 (USD Million)
TABLE 375 Mexico next generation sequencing market estimates & forecasts, by consumables, 2018 - 2030 (USD Million)
TABLE 376 Mexico next generation sequencing market estimates & forecasts, by sample preparation, 2018 - 2030 (USD Million)
TABLE 377 Mexico next generation sequencing market estimates & forecasts, by target enrichment, 2018 - 2030 (USD Million)
TABLE 378 Mexico next generation sequencing market estimates & forecasts, by other consumables, 2018 - 2030 (USD Million)
TABLE 379 Mexico next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 380 Mexico targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 381 Mexico next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 382 Mexico NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 383 Mexico NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 384 Mexico next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 385 MEA next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 386 MEA next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 387 MEA next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
TABLE 388 MEA next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
TABLE 389 MEA NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 390 MEA NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 391 MEA next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
TABLE 392 MEA next generation sequencing market estimates & forecasts, by product, 2018 - 2030 (USD Million)
TABLE 393 MEA next generation sequencing market estimates & forecasts, by platforms, 2018 - 2030 (USD Million)
TABLE 394 MEA next generation sequencing market estimates & forecasts, by sequencing platforms, 2018 - 2030 (USD Million)
TABLE 395 MEA next generation sequencing market estimates & forecasts, by data analysis platforms, 2018 - 2030 (USD Million)
TABLE 396 MEA next generation sequencing market estimates & forecasts, by consumables, 2018 - 2030 (USD Million)
TABLE 397 MEA next generation sequencing market estimates & forecasts, by sample preparation, 2018 - 2030 (USD Million)
TABLE 398 MEA next generation sequencing market estimates & forecasts, by target enrichment, 2018 - 2030 (USD Million)
TABLE 399 MEA next generation sequencing market estimates & forecasts, by other consumables, 2018 - 2030 (USD Million)
TABLE 400 MEA next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 401 MEA targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 402 MEA next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 403 MEA NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 404 MEA NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 405 MEA next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 406 South Africa next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 407 South Africa next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 408 South Africa next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
TABLE 409 South Africa next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
TABLE 410 South Africa NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 411 South Africa NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 412 South Africa next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
TABLE 413 South Africa next generation sequencing market estimates & forecasts, by product, 2018 - 2030 (USD Million)
TABLE 414 South Africa next generation sequencing market estimates & forecasts, by platforms, 2018 - 2030 (USD Million)
TABLE 415 South Africa next generation sequencing market estimates & forecasts, by sequencing platforms, 2018 - 2030 (USD Million)
TABLE 416 South Africa next generation sequencing market estimates & forecasts, by data analysis platforms, 2018 - 2030 (USD Million)
TABLE 417 South Africa next generation sequencing market estimates & forecasts, by consumables, 2018 - 2030 (USD Million)
TABLE 418 South Africa next generation sequencing market estimates & forecasts, by sample preparation, 2018 - 2030 (USD Million)
TABLE 419 South Africa next generation sequencing market estimates & forecasts, by target enrichment, 2018 - 2030 (USD Million)
TABLE 420 South Africa next generation sequencing market estimates & forecasts, by other consumables, 2018 - 2030 (USD Million)
TABLE 421 South Africa next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 422 South Africa targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 423 South Africa next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 424 South Africa NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 425 South Africa NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 426 South Africa next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 427 Saudi Arabia next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 428 Saudi Arabia next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 429 Saudi Arabia next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
TABLE 430 Saudi Arabia next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
TABLE 431 Saudi Arabia NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 432 Saudi Arabia NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
TABLE 433 Saudi Arabia next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
TABLE 434 Saudi Arabia next generation sequencing market estimates & forecasts, by product, 2018 - 2030 (USD Million)
TABLE 435 Saudi Arabia next generation sequencing market estimates & forecasts, by platforms, 2018 - 2030 (USD Million)
TABLE 436 Saudi Arabia next generation sequencing market estimates & forecasts, by sequencing platforms, 2018 - 2030 (USD Million)
TABLE 437 Saudi Arabia next generation sequencing market estimates & forecasts, by data analysis platforms, 2018 - 2030 (USD Million)
TABLE 438 Saudi Arabia next generation sequencing market estimates & forecasts, by consumables, 2018 - 2030 (USD Million)
TABLE 439 Saudi Arabia next generation sequencing market estimates & forecasts, by sample preparation, 2018 - 2030 (USD Million)
TABLE 440 Saudi Arabia next generation sequencing market estimates & forecasts, by target enrichment, 2018 - 2030 (USD Million)
TABLE 441 Saudi Arabia next generation sequencing market estimates & forecasts, by other consumables, 2018 - 2030 (USD Million)
TABLE 442 Saudi Arabia next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 443 Saudi Arabia targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
TABLE 444 Saudi Arabia next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 445 Saudi Arabia NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 446 Saudi Arabia NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
TABLE 447 Saudi Arabia next generation sequencing market estimates & forecasts, by end--use, 2018 - 2030 (USD Million)


List of Figures

FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value chain-based sizing & forecasting
FIG. 6 QFD modelling for market share assessment
FIG. 7 Market summary part-1
FIG. 8 Market summary part-2
FIG. 9 Generations of sequencing
FIG. 10 Different NGS technologies and type of analysis
FIG. 11 Common DNA sequencing methods
FIG. 12 Examples of NGS cost per sample
FIG. 13 Key end users: NGS market
FIG. 14 Key end users, by product: NGS market
FIG. 15 Comparison of next-generation sequencing technologies and Sanger sequencing
FIG. 16 Overview of sequencing technology timeline
FIG. 17 Key macroeconomic challenges associated with the pandemic
FIG. 18 Key elements to enhance the supply chain post COVID
FIG. 19 Role of NGS to combat COVID-19 outbreak
FIG. 20 Workflow Comparison
FIG. 21 Market trends & outlook
FIG. 22 Market segmentation & scope
FIG. 23 Market driver relevance analysis (Current & future impact)
FIG. 24 Cost per raw megabase (Mb) of DNA sequence (USD)
FIG. 25 Cost per genome
FIG. 26 Expected rise in expenditure for cancer treatment (USD Billion)
FIG. 27 Global cancer prevalence
FIG. 28 Market restraint relevance analysis (Current & future impact)
FIG. 29 Percentage of NGS sequencing reimbursement from payers
FIG. 30 Bottlenecks associated with implementation of NGS
FIG. 31 Penetration & growth prospect mapping for applications, 2021
FIG. 32 Penetration & growth prospect mapping for prominent industry players, 2021
FIG. 33 NGS platform penetration mapping, 2021
FIG. 34 Payer perspectives for developing coverage policy for Next-Generation Tumour Sequencing Panels (NGTS)
FIG. 35 Next generation sequencing market: Regional market share, 2021
FIG. 36 Next generation sequencing North America regulatory and political landscape analysis, 2021
FIG. 37 Next generation sequencing Europe regulatory and political landscape analysis, 2021
FIG. 38 Next generation sequencing Asia Pacific regulatory and political landscape analysis, 2021
FIG. 39 Next generation sequencing Latin America regulatory and political landscape analysis, 2021
FIG. 40 Next generation sequencing Middle East & Africa regulatory and political landscape analysis 2019
FIG. 41 SWOT Analysis, By Factor (political & legal, economic and technological)
FIG. 42 Porter's Five Forces Analysis
FIG. 43 Potentially actionable genes considered during the study
FIG. 44 Study results
FIG. 45 Company categorization
FIG. 46 Service providers, manufacturers, & suppliers of products
FIG. 47 Service providers
FIG. 48 Service providers
FIG. 49 Service providers
FIG. 50 NGS market share, by company, 2021 (%)
FIG. 51 Competitive dashboard analysis
FIG. 52 Regional distribution for private companies
FIG. 53 Penetration & growth prospect mapping for private companies, 2021
FIG. 54 Next generation sequencing market: Application outlook key takeaways
FIG. 55 Next generation sequencing market: Application movement analysis
FIG. 56 Global oncology market, 2018 - 2030 (USD Million)
FIG. 57 Diagnostics and screening market, 2018 - 2030 (USD Million)
FIG. 58 Oncology screening market, 2018 - 2030 (USD Million)
FIG. 59 Sporadic cancer screening market, 2018 - 2030 (USD Million)
FIG. 60 Inherited cancer screening market, 2018 - 2030 (USD Million)
FIG. 61 Companion diagnostics market, 2018 - 2030 (USD Million)
FIG. 62 Other diagnostics market, 2018 - 2030 (USD Million)
FIG. 63 Research studies market, 2018 - 2030 (USD Million)
FIG. 64 Global clinical investigation market, 2018 - 2030 (USD Million)
FIG. 65 Global infectious diseases market, 2018 - 2030 (USD Million)
FIG. 66 Global inherited diseases market, 2018 - 2030 (USD Million)
FIG. 67 Global idiopathic diseases market, 2018 - 2030 (USD Million)
FIG. 68 Global non-communicable/other diseases market, 2018 - 2030 (USD Million)
FIG. 69 Global reproductive health market, 2018 - 2030 (USD Million)
FIG. 70 Global NIPT market, 2018 - 2030 (USD Million)
FIG. 71 Global aneuploidy market, 2018 - 2030 (USD Million)
FIG. 72 Global microdeletions market, 2018 - 2030 (USD Million)
FIG. 73 Global NGS PGT market, 2018 - 2030 (USD Million)
FIG. 74 Global new-born/genetic screening market, 2018 - 2030 (USD Million)
FIG. 75 Single gene analysis market, 2018 - 2030 (USD Million)
FIG. 76 Global HLA typing/immune system monitoring market, 2018 - 2030 (USD Million)
FIG. 77 Global metagenomics, epidemiology & drug development market, 2018 - 2030 (USD Million)
FIG. 78 Global agrigenomics & forensics market, 2018 - 2030 (USD Million)
FIG. 79 Global consumer genomics market, 2018 - 2030 (USD Million)
FIG. 80 Next generation sequencing market: Product outlook key takeaways
FIG. 81 Global next-generation sequencing market: product movement analysis
FIG. 82 Global platforms market, 2018 - 2030 (USD Million)
FIG. 83 Global sequencing market, 2018 - 2030 (USD Million)
FIG. 84 Global data analysis market, 2018 - 2030 (USD Million)
FIG. 85 Global consumables market, 2018 - 2030 (USD Million)
FIG. 86 Global sample preparation market, 2018 - 2030 (USD Million)
FIG. 87 Global target enrichment market, 2018 - 2030 (USD Million)
FIG. 88 Global other consumables market, 2018 - 2030 (USD Million)
FIG. 89 Next generation sequencing market: Technology outlook key takeaways
FIG. 90 Global next-generation sequencing market: Technology movement analysis
FIG. 91 Global whole genome sequencing market, 2018 - 2030 (USD Million)
FIG. 92 Global whole exome sequencing market, 2018 - 2030 (USD Million)
FIG. 93 Global targeted sequencing & resequencing market, 2018 - 2030 (USD Million)
FIG. 94 Global DNA based targeted sequencing & resequencing market, 2018 - 2030 (USD Million)
FIG. 95 Global RNA based targeted sequencing & resequencing market, 2018 - 2030 (USD Million)
FIG. 96 Next generation sequencing market Workflow outlook key takeaways
FIG. 97 Next generation sequencing market: Workflow movement analysis
FIG. 98 Global pre-sequencing market, 2018 - 2030 (USD Million)
FIG. 99 Global NGS library preparation kits market, 2018 - 2030 (USD Million)
FIG. 100 Global NGS semi-automated library preparation market, 2018 - 2030 (USD Million)
FIG. 101 Global NGS automated library preparation market, 2018 - 2030 (USD Million)
FIG. 102 Global clonal amplification market, 2018 - 2030 (USD Million)
FIG. 103 Global Sequencing market, 2018 - 2030 (USD Million)
FIG. 104 Global data analysis market, 2018 - 2030 (USD Million)
FIG. 105 Global NGS primary data analysis market, 2018 - 2030 (USD Million)
FIG. 106 Global NGS secondary data analysis market, 2018 - 2030 (USD Million)
FIG. 107 Global NGS tertiary data analysis market, 2018 - 2030 (USD Million)
FIG. 108 Next generation sequencing market End-use outlook key takeaways
FIG. 109 Next generation sequencing market: End-use movement analysis
FIG. 110 Global academic research market, 2018 - 2030 (USD Million)
FIG. 111 Global clinical research market, 2018 - 2030 (USD Million)
FIG. 112 Global hospitals & clinics market, 2018 - 2030 (USD Million)
FIG. 113 Global pharma & biotech entities market, 2018 - 2030 (USD Million)
FIG. 114 Global other users market, 2018 - 2030 (USD Million)
FIG. 115 Regional marketplace: Key takeaway
FIG. 116 Regional Sequencing Capacity Mapping
FIG. 117 Next generation regional outlook, 2020 & 2030
FIG. 118 Top players in North America
FIG. 119 Top players in Europe
FIG. 120 Top players in Asia Pacific
FIG. 121 Top players in Latin America and Middle East & Africa
FIG. 122 North America next-generation sequencing market, 2018 - 2030 (USD Million)
FIG. 123 U.S. next-generation sequencing market, 2018 - 2030 (USD Million)
FIG. 124 Canada next-generation sequencing market, 2018 - 2030 (USD Million)
FIG. 125 Europe next-generation sequencing market, 2018 - 2030 (USD Million)
FIG. 126 Germany next-generation sequencing market, 2018 - 2030 (USD Million)
FIG. 127 Spain next-generation sequencing market, 2018 - 2030 (USD Million)
FIG. 128 France next-generation sequencing market, 2018 - 2030 (USD Million)
FIG. 129 Italy next-generation sequencing market, 2018 - 2030 (USD Million)
FIG. 130 UK next-generation sequencing market, 2018 - 2030 (USD Million)
FIG. 131 Asia Pacific next-generation sequencing market, 2018 - 2030 (USD Million)
FIG. 132 Japan next-generation sequencing market, 2018 - 2030 (USD Million)
FIG. 133 China next-generation sequencing market, 2018 - 2030 (USD Million)
FIG. 134 India next-generation sequencing market, 2018 - 2030 (USD Million)
FIG. 135 Australia next-generation sequencing market, 2018 - 2030 (USD Million)
FIG. 136 South Korea next-generation sequencing market, 2018 - 2030 (USD Million)
FIG. 137 Latin America. next-generation sequencing market, 2018 - 2030 (USD Million)
FIG. 138 Brazil next-generation sequencing market, 2018 - 2030 (USD Million)
FIG. 139 Mexico next-generation sequencing market, 2018 - 2030 (USD Million)
FIG. 140 Middle East & Africa. next-generation sequencing market, 2018 - 2030 (USD Million)
FIG. 141 South Africa next-generation sequencing market, 2018 - 2030 (USD Million)
FIG. 142 Saudi Arabia next-generation sequencing market, 2018 - 2030 (USD Million)
FIG. 143 Strategy framework
FIG. 144 Participant categorization
FIG. 145 Next-generation sequencing vendor's landscape

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

D&B icon

Leading SME award by D&B

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon